Safe & Easy Environment at Home for Patients Presenting a Frail Syndrome
NCT ID: NCT02288221
Last Updated: 2025-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
4 participants
INTERVENTIONAL
2015-06-04
2017-07-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Building a global system aiming to take in charge all causes leading to loss of autonomy is a rather complicated task involving numerous Information and Communication technologies (ICT) solutions which are not always easy to use in everyday life.
The SafEE (Safe Easy Environment) project aim is to improve the safety, autonomy and quality of life of older people at risk.
The SafEE project develop non pharmacological therapeutic through diferent ICT (stimulation aromatherapy automatic fragrance, training interface based on Kinect sensor...) .
The goal of this study is to validate the acceptability, sensitivity and efficacy of the systems.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safe & Easy for Alzheimer's Disease and Related Pathologies
NCT02518243
Determinant of the Risk of the Becoming Frail in the Non-dependent Elederly
NCT04012840
Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults
NCT05961319
Determinants of Frailty Among of Informal Caregivers of Demented Patient
NCT03994562
A Practical Platform for In-Home Remote Monitoring of Cognitive Frailty
NCT05754021
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* aromatherapy,
* music therapy,
* cognitive training in multimedia application offering cognitive games.
Also smart phone will be given to the patient :
* to help him move with a geolocation application,
* to remind him of his daily needs (shopping lists, people to call, etc ...) with an alert apllication.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
With non pharmacological therapeutic
Installation of ICT at patient's home
Patient's answer with non pharmacological therapeutic
Installation at patient's home of :
* aromatherapy
* music therapy
* cognitive training in multimedia application offering cognitive games
Without non pharmacological therapeutic
No change at patient's home
Patient's answer without non pharmacological therapeutic
No installation at patient's home
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient's answer with non pharmacological therapeutic
Installation at patient's home of :
* aromatherapy
* music therapy
* cognitive training in multimedia application offering cognitive games
Patient's answer without non pharmacological therapeutic
No installation at patient's home
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Score at the Mini Mental Test (MMSE) ≥ 26.
* Score at the Clinical Dementia Rating Scale (CDR) ≤ 0.5.
Exclusion Criteria
* Prescription new psychotropic medication (hypnotic, anxiolytic, antidepressant, antipsychotic) in the week preceding the assessment.
* Subject epileptic.
* Subject vulnerable
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Renaud DAVID, Dr
Role: STUDY_DIRECTOR
Centre Hospitalier Universitaire de Nice
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Claude Pompidou
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-PP-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.